You are here

Ferumoxytol

AMAG To Get $15 Million Milestone Payment From Takeda as Iron Therapy Drug Approved for Europe

WSJ

Sat, 06/23/12 - 01:14 pm

Amag Pharmaceuticals

AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease

Enhanced Online News

Sat, 04/21/12 - 01:24 pm

Amag Pharmaceuticals

chronic kidney disease

Amag Pharma Bulls Still Have Hope

The Street

Wed, 12/24/08 - 10:35 am

Amag Pharmaceuticals